Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [The use of bisphosphonates in arthroplasty].

Literature DB >> 17219189

[The use of bisphosphonates in arthroplasty].

Abstract

The use of bisphosphonates in joint arthroplasty is the latest field of application for these agents. The mechanism of action of bisphosphonates suggests that they may optimize long-term survival of the implant. Most important is their potency in suppressing periprosthetic osteolysis due to the inflammatory foreign body reaction of wear debris, to decrease periprosthetic osteopenia caused by stress-shielding and to improve the osseointegration of cementless metal implants. The present review provides the latest information on definite and presumed mechanisms of action of bisphosphonates and their clinical importance.

Entities: Chemical Disease

Mesh：

Substances：

Year: 2007 PMID： 17219189 DOI： 10.1007/s00132-006-1038-3

Source DB: PubMed Journal: Orthopade ISSN： 0085-4530 Impact factor: 1.087

23 in total

1. Effect of pamidronate in preventing local bone loss after total hip arthroplasty: a randomized, double-blind, controlled trial.

Authors: J M Wilkinson; I Stockley; N F Peel; A J Hamer; R A Elson; N A Barrington; R Eastell
Journal: J Bone Miner Res Date: 2001-03 Impact factor: 6.741

2. Bisphosphonates in bone cement inhibit PMMA particle induced bone resorption.

Authors: A Sabokbar; Y Fujikawa; D W Murray; N A Athanasou
Journal: Ann Rheum Dis Date: 1998-10 Impact factor: 19.103

3. Acetabular cup migration. Prediction of aseptic loosening.

Authors: G W Stocks; M A Freeman; S J Evans
Journal: J Bone Joint Surg Br Date: 1995-11

4. Observations on the effect of movement on bone ingrowth into porous-surfaced implants.

Authors: R M Pilliar; J M Lee; C Maniatopoulos
Journal: Clin Orthop Relat Res Date: 1986-07 Impact factor: 4.176

5. The John Charnley Award. Inhibition of wear debris mediated osteolysis in a canine total hip arthroplasty model.

Authors: A S Shanbhag; C T Hasselman; H E Rubash
Journal: Clin Orthop Relat Res Date: 1997-11 Impact factor: 4.176

6. Alendronate did not inhibit instability-induced bone resorption. A study in rats.

Authors: J Astrand; P Aspenberg
Journal: Acta Orthop Scand Date: 1999-02

7. Effect of alendronate on periprosthetic bone loss after total knee arthroplasty: a one-year, randomized, controlled trial of 19 patients.

Authors: T A Soininvaara; J S Jurvelin; H J A Miettinen; O T Suomalainen; E M Alhava; P J Kröger
Journal: Calcif Tissue Int Date: 2002-10-10 Impact factor: 4.333

Review 8. Bone morphogenetic protein-2: biology and applications.

Authors: E H Riley; J M Lane; M R Urist; K M Lyons; J R Lieberman
Journal: Clin Orthop Relat Res Date: 1996-03 Impact factor: 4.176

9. [Effect of alendronate on periprosthetic bone loss after cemented primary total hip arthroplasty: a prospective randomized study].

Authors: A Nehme; G Maalouf; J-L Tricoire; G Giordano; P Chiron; J Puget
Journal: Rev Chir Orthop Reparatrice Appar Mot Date: 2003-11